{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:06:30Z","timestamp":1783393590288,"version":"3.54.6"},"reference-count":18,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T00:00:00Z","timestamp":1520467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0193986","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T18:36:09Z","timestamp":1520534169000},"page":"e0193986","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Beneficial effects of fingolimod in MS patients with high serum Sema4A levels"],"prefix":"10.1371","volume":"13","author":[{"given":"Toru","family":"Koda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Namba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Nakatsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Niino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusei","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazushiro","family":"Takata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikito","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Fukazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kumanogoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6173-3759","authenticated-orcid":true,"given":"Tatsusada","family":"Okuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,3,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Multiple sclerosis","volume":"343","author":"JH Noseworthy","year":"2000","journal-title":"N Engl J Med"},{"key":"ref2","article-title":"Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis","volume":"9","author":"I Tramacere","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S1474-4422(11)70099-0","article-title":"Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study","volume":"10","author":"B Khatri","year":"2011","journal-title":"Lancet Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ana.22426","article-title":"Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis","volume":"69","author":"JA Cohen","year":"2011","journal-title":"Ann Neurol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nature01037","article-title":"Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2","volume":"419","author":"A Kumanogoh","year":"2002","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.4049\/jimmunol.1102023","article-title":"Elevation of Sema4A implicates Th cell skewing and the efficacy of IFN-\u03b2 therapy in multiple sclerosis","volume":"188","author":"Y Nakatsuji","year":"2012","journal-title":"J Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jneuroim.2013.12.014","article-title":"Sema4A inhibits the therapeutic effect of IFN-\u03b2 in EAE","volume":"268","author":"T Koda","year":"2014","journal-title":"J Neuroimmunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/1346-8138.12085","article-title":"Aberrant epidermal expression of semaphorin 3A and nerve growth factor in prurigo nodularis","volume":"40","author":"S Takada","year":"2013","journal-title":"J Dermatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0165-2478(01)00339-X","article-title":"Gender does not influence the susceptibility of C57BL\/6 mice to develop chronic experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein","volume":"81","author":"Y Okuda","year":"2002","journal-title":"Immunol Lett"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1212\/WNL.0b013e3182535cf6","article-title":"Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFN\u03b2-1b trial","volume":"78","author":"DS Goodin","year":"2012","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/ana.20740","article-title":"Defining the response to interferon-beta in relapsing-remitting multiple sclerosis patients","volume":"59","author":"J Rio","year":"2006","journal-title":"Ann Neurol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S1474-4422(13)70192-3","article-title":"Emerging injectable therapies for multiple sclerosis","volume":"12","author":"J Oh","year":"2013","journal-title":"Lancet Neurol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S1474-4422(11)70228-9","article-title":"Oral treatment for multiple sclerosis","volume":"10","author":"J Killestein","year":"2011","journal-title":"Lancet Neurol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.immuni.2005.01.014","article-title":"Nonredundant roles of Sema4A in the immune system: defective T cell priming and Th1\/Th2 regulation in Sema4A-deficient mice","volume":"22","author":"A Kumanogoh","year":"2005","journal-title":"Immunity"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.tips.2010.11.002","article-title":"Sphingosine-1-phosphate and immune regulation: trafficking and beyond","volume":"32","author":"H Chi","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1073\/pnas.1014154108","article-title":"FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation","volume":"108","author":"JW Choi","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ana.24217","article-title":"Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide","volume":"76","author":"E Colombo","year":"2014","journal-title":"Ann Neurol"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.1177\/1759091415587502","article-title":"Semaphorin4A is cytotoxic to oligodendrocytes and is elevated in microglia and multiple sclerosis","volume":"7","author":"DF Leitner","year":"2015","journal-title":"ASN Neuro"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0193986","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:00:16Z","timestamp":1588964416000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0193986"}},"subtitle":[],"editor":[{"given":"Akio","family":"Suzumura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,3,8]]},"references-count":18,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0193986","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,8]]}}}